Qiagen AG - Switzerland Q4 Profit Up 65% on Demand for Test Kits

February 10, 2009 |

1 min read

FRANKFURT, Feb 9 (Reuters) - Genetic-testing company Qiagen posted a 65 percent gain in fourth-quarter net profit, above expectations, as it sold more testing kits for a virus that causes cervical cancer.

Earnings Europe

MORE ON THIS TOPIC

Pleasanton, CA, USA - Feb 21, 2024: Exterior view of the headquarters of Roche Molecular Diagnostics (RMD) in Pleasanton, California. F. Hoffmann-La Roche AG is a Swiss pharmaceutical company.

Antibody-drug conjugate (ADC)

Roche Inks Another China ADC Pact With $1.5B Hansoh Bet

October 17, 2025

·

2 min read

·

Tristan Manalac

Creative collage illustration of financial business. Two businessmen shaking hands for partners agreement. Conceptual illustration of success deal, corporate ethic, connection.

Collaboration

Kite Makes $1.5B+ Cell Therapy Pact With Pregene as Others Pull Back

October 17, 2025

·

2 min read

·

Tristan Manalac

Gentilly, France, March 21, 2021: Exterior view of the Sanofi headquarters building. Sanofi is a French multinational company specializing in the health sector

Autoimmune disease

Sanofi Joins With EVOQ in $500M Autoimmune Alliance

October 16, 2025

·

2 min read

·

Tristan Manalac

3D illustration of hair root growing from skin cells, symbolizing strength, growth, and nourishment. Perfect for haircare, cosmetic advertising, medical research, and healthcare concepts.

Funding

Veradermics Gets $150M Series C To Advance Hair Regrowth Pill

October 16, 2025

·

2 min read

·

Tristan Manalac